Generic drugs in the US are too cheap to be sustainable, experts say
by Jessica Glenza from Science | The Guardian on (#6HYNF)
Non-brand-name drugs are one inexpensive part of the healthcare system but they're driving some manufacturers out of business
Generic drugs are the singularity of American healthcare - they are too cheap. And it's driving some manufacturers out of business altogether.
Drug prices regularly spark recrimination and outrage on Capitol Hill, such as a recently announced investigation by Senate Democrats and Bernie Sanders into the price of albuterol inhalers.
Continue reading...